Pharmacy

On or before September 1, CMS will release the names of the 10 Part D drugs subject to negotiated prices starting in 2026.

The new program would allow for monthly payments over a year.

The nasal-spray vaccine will not require refrigeration and does not need to be administered by a medical professional.

The initiative is designed to lower prescription medication costs by roughly $500 million annually once the model is fully implemented.

Many insulin brands are available to eligible customers starting at $35 a month, the company says.

These improvements are likely driven by the continued opioid crisis and the concurrent growth in demand for affordable SUD treatment.

A new vaccine for the latest variant is expected to be available at the end of September.

<p>Technology can help dampen the noise by adding lab values, comorbidities and risk scores to patient information to refine the alert, says Anna Dover, director of product management at FDB (formerly First Databank).</p>

Hospitals and physician practices are increasingly competing against retail pharmacies in the primary care market. 

CMS also releases the 2024 Part D national average monthly bid amount to help Plan D sponsors finalize their premiums.